Focus Partners Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-300
Closed -$234K 2266
2025
Q2
$234K Hold
300
﹤0.01% 1791
2025
Q1
$248K Sell
300
-600
-67% -$499K ﹤0.01% 1664
2024
Q4
$695K Hold
900
﹤0.01% 1187
2024
Q3
$797K Buy
+900
New +$809K ﹤0.01% 1008

Other funds holding LLY

Focus Partners Wealth's LLY Position: Q2 2026 in Review

Focus Partners Wealth increased its Eli Lilly (LLY) stake by 9.7% in Q2 2026, buying an estimated $23.4M and bringing the position to 260,045 shares worth $312M. The position accounts for 0.32% of the portfolio, ranked #64.

Focus Partners Wealth first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Focus Partners Wealth held 260,045 shares of Eli Lilly worth $312M as of Q2 2026.
  • Focus Partners Wealth bought 22,920 Eli Lilly shares in Q2 2026, an estimated $23.4M.
  • Eli Lilly made up 0.32% of Focus Partners Wealth's portfolio in Q2 2026, its #64 holding.
  • Focus Partners Wealth first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Focus Partners Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.